<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mlc" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mlc</book-part-id>
      <title-group>
        <title>Megalencephalic Leukoencephalopathy with Subcortical Cysts</title>
        <alt-title alt-title-type="alt-title">Synonyms: Vacuolating Megalencephalic Leukoencephalopathy with Subcortical Cysts, Van der Knaap Disease</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van der Knaap</surname>
            <given-names>Marjo S</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Professor, Department of Child Neurology<break/>Vrije Universiteit Medical Center<break/>Amsterdam, Netherlands</aff>
          <email>ms.vanderknaap@vumc.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Scheper</surname>
            <given-names>Gert C</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Assistant Professor, Pediatrics and Child Neurology<break/>Vrije Universiteit Medical Center<break/>Amsterdam, Netherlands</aff>
          <email>gc.scheper@vumc.nl</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>11</day>
          <month>8</month>
          <year>2003</year>
        </date>
        <date date-type="updated">
          <day>3</day>
          <month>11</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mcad" document-type="chapter">Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="miccap-ms" document-type="chapter">Microcephaly-Capillary Malformation Syndrome</related-object>
      <abstract id="mlc.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The <italic toggle="yes">classic phenotype</italic> of megalencephalic leukoencephalopathy with subcortical cysts (MLC) is characterized by early-onset macrocephaly, often in combination with mild gross motor developmental delay and seizures; gradual onset of ataxia, spasticity, and sometimes extrapyramidal findings; and usually late onset of mild mental deterioration. Macrocephaly, observed in all individuals, may be present at birth but more frequently develops during the first year of life. The degree of macrocephaly is variable and can be as great as 4 to 6 SD above the mean in some individuals. After the first year of life, head growth rate normalizes and growth follows a line parallel to the 98th percentile, usually several centimeters above it. Almost all individuals have epilepsy from an early age. Initial mental and motor development is normal in most cases. Walking is often unstable, followed by ataxia of the trunk and extremities, then minor signs of pyramidal dysfunction and brisk deep-tendon stretch reflexes. Mental deterioration is late and mild. Severity ranges from independent walking for a few years only to independent walking in the fifth decade. Some individuals have died in their teens or twenties; others are alive in their forties.</p>
          <p>An atypical <italic toggle="yes">improving phenotype</italic> has a similar initial presentation without mental or motor regression, followed by an improving clinical course: motor and cognitive functions improve or normalize; macrocephaly usually persists, but some children become normocephalic; hypotonia and clumsiness may persist in some or neurologic examination may become normal. Some have intellectual disability that is stable with or without autism.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of MLC is established in individuals with typical clinical findings and characteristic abnormalities observed on cranial MRI, including abnormal and swollen cerebral hemispheric white matter and presence of subcortical cysts in the anterior temporal region and often in the frontoparietal region. When associated with biallelic mutation of <italic toggle="yes">MLC1</italic>, the classic phenotype is known as MLC1; when caused by biallelic mutation of <italic toggle="yes">HEPACAM</italic> it is known as MLC2A. The improving phenotype associated with heterozygous mutation of <italic toggle="yes">HEPACAM</italic> is known as MLC2B. Pathogenic variants in <italic toggle="yes">MLC1</italic> are observed in approximately 75% of persons with MLC; pathogenic variants in <italic toggle="yes">HEPACAM</italic> are found in approximately 20%.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Antiepileptic drugs (AEDs) to control epileptic seizures; physical therapy to improve motor function; special education.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>MLC1 and MLC2A are inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal diagnosis for pregnancies at increased risk are possible if both pathogenic alleles have been identified in the family.</p>
          <p>MLC2B is inherited in an autosomal dominant manner. <italic toggle="yes">De novo</italic> pathogenic variants are common. Each child of an individual with MLC2B has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the disease-causing allele has been identified in the family</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mlc.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mlc.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of megalencephalic leukoencephalopathy with subcortical cysts (MLC) can be made with confidence in individuals with typical clinical findings and characteristic abnormalities on cranial magnetic resonance imaging (MRI) [<xref ref-type="bibr" rid="mlc.REF.van_der_knaap.1995.324">van der Knaap et al 1995</xref>, <xref ref-type="bibr" rid="mlc.REF.singhal.1996.291">Singhal et al 1996</xref>, <xref ref-type="bibr" rid="mlc.REF.top_u.1998.142">Top&#x000e7;u et al 1998</xref>].</p>
          <sec id="mlc.Typical_Clinical_Findings">
            <title>Typical Clinical Findings</title>
            <p>
              <bold>Classic phenotype</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Macrocephaly is present at birth or (more commonly) develops within the first year of life in all individuals. After the first year of life, head growth rate becomes normal; growth usually follows a line above and parallel to the 98th centile.</p>
              </list-item>
              <list-item>
                <p>Early development is normal or mildly delayed. Most (not all) children achieve independent walking.</p>
              </list-item>
              <list-item>
                <p>Slow deterioration of motor functions with cerebellar ataxia and mild spasticity usually starts in early childhood or later. The majority of affected children become wheelchair dependent in their teens.</p>
              </list-item>
              <list-item>
                <p>Speech can become increasingly dysarthric; dysphagia may develop.</p>
              </list-item>
              <list-item>
                <p>Some individuals have extrapyramidal movement abnormalities with dystonia and athetosis, usually as a late finding. Tics may occur.</p>
              </list-item>
              <list-item>
                <p>Mental decline occurs later and is much milder than motor decline.</p>
              </list-item>
              <list-item>
                <p>Some affected individuals develop behavioral problems.</p>
              </list-item>
              <list-item>
                <p>Most individuals have epileptic seizures that are usually easily controlled with medication; however, some experience status epilepticus.</p>
              </list-item>
              <list-item>
                <p>Minor head trauma may induce temporary deterioration in some individuals, most often observed as seizures, prolonged unconsciousness, or acute motor deterioration with gradual improvement.</p>
              </list-item>
            </list>
            <p>When associated with biallelic mutation of <italic toggle="yes">MLC1</italic>, the classic phenotype is known as MLC1; when caused by biallelic mutation of <italic toggle="yes">HEPACAM</italic> it is known as MLC2A.</p>
            <p>
              <bold>Improving phenotype</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Macrocephaly is present at birth or (more commonly) develops within the first year of life in all individuals. After the first year of life, growth of the head usually follows a line above and parallel to the 98th centile. In a few children the head circumference normalizes.</p>
              </list-item>
              <list-item>
                <p>Early development is normal or mildly delayed. All children achieve independent walking.</p>
              </list-item>
              <list-item>
                <p>Motor function improves after first year of life; clumsiness and hypotonia persist in some.</p>
              </list-item>
              <list-item>
                <p>Some affected individuals have seizures that are usually easily controlled with medication; however, some experience status epilepticus.</p>
              </list-item>
              <list-item>
                <p>Some have a stable intellectual disability, with or without autism.</p>
              </list-item>
              <list-item>
                <p>Regression of mental and motor functions does not occur.</p>
              </list-item>
            </list>
            <p>The improving phenotype associated with heterozygous mutation of <italic toggle="yes">HEPACAM</italic> is known as MLC2B.</p>
          </sec>
          <sec id="mlc.MRI_Criteria">
            <title>MRI Criteria</title>
            <p>MRI of the brain is diagnostic (see <xref ref-type="fig" rid="mlc.F1">Figure 1</xref>):</p>
            <list list-type="bullet">
              <list-item>
                <p>Cerebral hemispheric white matter is diffusely abnormal and mildly swollen; see <xref ref-type="fig" rid="mlc.F1">Figure 1A</xref> (from an individual with MLC1) as compared to <xref ref-type="fig" rid="mlc.F1">Figure 1B</xref> (from an unaffected child).</p>
              </list-item>
              <list-item>
                <p>Central white matter structures, including the corpus callosum, internal capsule, and brain stem, are better preserved than other structures, although they are not usually entirely normal.</p>
              </list-item>
              <list-item>
                <p>Cerebellar white matter usually has a mildly abnormal signal and is not swollen.</p>
              </list-item>
              <list-item>
                <p>Subcortical cysts are almost invariably present in the anterior temporal region and often in the frontoparietal region as observed in <xref ref-type="fig" rid="mlc.F1">Figure 1C</xref> (from an individual with MLC1) as compared to <xref ref-type="fig" rid="mlc.F1">Figure 1D</xref> (from an unaffected child).</p>
              </list-item>
              <list-item>
                <p>Over time, the white matter swelling decreases; and cerebral atrophy ensues. The subcortical cysts may increase in size and number. In some individuals, the cysts become huge, occupying a large part of the frontoparietal white matter. In others, the cerebral white matter abnormalities decrease over time; and the signal intensity of the cerebral white matter becomes less abnormal.</p>
              </list-item>
              <list-item>
                <p>Diffusion-weighted imaging reveals increased diffusivity of abnormal white matter [<xref ref-type="bibr" rid="mlc.REF.itoh.2006.243">Itoh et al 2006</xref>, <xref ref-type="bibr" rid="mlc.REF.van_der_voorn.2006.510">van der Voorn et al 2006</xref>].</p>
              </list-item>
              <list-item>
                <p>In children with MLC2B, MRI early within the first year of life shows the same abnormalities as described above; however, striking improvement occurs on follow up. In some children the MRI becomes normal in a few years, whereas in others minor frontal and temporal subcortical white matter abnormalities and anterior temporal cysts remain.</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="mlc.Testing">
          <title>Testing</title>
          <p>Routine laboratory tests, including cerebrospinal fluid analysis, are normal.</p>
          <p><bold>Neuropathologic examination.</bold> Brain biopsy shows the presence of numerous vacuoles between the outer lamellae of myelin sheaths, suggesting splitting of these lamellae along the intraperiod line or incomplete compaction [<xref ref-type="bibr" rid="mlc.REF.van_der_knaap.1996.206">van der Knaap et al 1996</xref>]. In addition, small vacuoles are observed in astrocytic end feet [<xref ref-type="bibr" rid="mlc.REF.duarri.2011.228">Duarri et al 2011</xref>].</p>
          <sec id="mlc.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Genes.</bold> Megalencephalic leukoencephalopathy with subcortical cysts is caused by pathogenic variants in <italic toggle="yes">MLC1</italic> or <italic toggle="yes">HEPACAM.</italic></p>
            <p><bold>Possible further locus heterogeneity.</bold> When the clinical and MRI findings are characteristic of MLC, the absence of identified <italic toggle="yes">MLC1</italic> or <italic toggle="yes">HEPACAM</italic> pathogenic variants does not exclude the diagnosis of MLC because (1) the <italic toggle="yes">MLC1</italic> or <italic toggle="yes">HEPACAM</italic> pathogenic variants may not be identifiable with testing methods used or (2) the MLC phenotype may be the result of pathogenic variant(s) in another as-yet unidentified gene.</p>
            <table-wrap id="mlc.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Megalencephalic Leukoencephalopathy with Subcortical Cysts</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Proportion of MLC Attributed to Pathogenic Variants in This Gene</th>
                    <th id="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MLC1</italic>
                    </td>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">75%&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">(Multi)exon or whole-gene deletion/duplication&#x000a0;<sup>6</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                      <italic toggle="yes">HEPACAM</italic>
                    </td>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">20%&#x000a0;<sup>7</sup></td>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis</td>
                    <td headers="hd_h_mlc.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>4</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mlc.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="mlc" object-id="mlc.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="mlc.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="mlc.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="mlc.TF.1.3">
                  <label>3. </label>
                  <p>Sequence analysis of the coding region of <italic toggle="yes">MLC1</italic> genomic DNA detects homozygous or compound heterozygous variants in approximately 65% to 70% of individuals with clinical and MRI presentation of MLC. Large deletions and some deep intronic variants in <italic toggle="yes">MLC1</italic> are not detected and require deletion/duplication analysis or cDNA sequencing. If extensive analysis of genomic DNA and cDNA does not reveal any pathogenic variants in <italic toggle="yes">MLC1</italic>, it is assumed that the individual has variants in another gene, most likely <italic toggle="yes">HEPACAM</italic>. Complementary DNA is not always available so it is possible that some variants in <italic toggle="yes">MLC1</italic> are missed by the standard genomic DNA sequencing of exons and surrounding intronic regions.</p>
                </fn>
                <fn id="mlc.TF.1.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="mlc.TF.1.5">
                  <label>5. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; a variety of methods including quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), or targeted chromosomal microarray analysis (gene/segment-specific) may be used. A full chromosomal microarray analysis that detects deletions/duplications across the genome may also include this gene/segment.</p>
                </fn>
                <fn id="mlc.TF.1.6">
                  <label>6. </label>
                  <p><xref ref-type="bibr" rid="mlc.REF.leegwater.2002.279">Leegwater et al [2002]</xref>, <xref ref-type="bibr" rid="mlc.REF.ilja_boor.2006.505">Ilja Boor et al [2006]</xref></p>
                </fn>
                <fn id="mlc.TF.1.7">
                  <label>7. </label>
                  <p>Sequence analysis of the coding region of <italic toggle="yes">HEPACAM</italic> genomic DNA detects pathogenic variants in approximately 75% of persons with MLC with no identifiable <italic toggle="yes">MLC1</italic> pathogenic variant: two thirds have heterozygous <italic toggle="yes">HEPACAM</italic> pathogenic variants (i.e., MLC2B), one third have biallelic <italic toggle="yes">HEPACAM</italic> pathogenic variants (i.e., MLC2A) [<xref ref-type="bibr" rid="mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</xref>].</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>
              <bold>Interpretation of test results</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Finding two pathogenic variants in <italic toggle="yes">MLC1</italic> or <italic toggle="yes">HEPACAM</italic> confirms the diagnosis of MLC1 and MLC2A, respectively, and the classic phenotype of MLC.</p>
              </list-item>
              <list-item>
                <p>Finding one pathogenic variant in <italic toggle="yes">HEPACAM</italic> in combination with improvement of MRI on follow-up confirms the diagnosis of autosomal dominant MLC2B, the improving phenotype of MLC.</p>
              </list-item>
              <list-item>
                <p>When the clinical and MRI findings are characteristic of MLC, the absence of identified <italic toggle="yes">MLC1</italic> or <italic toggle="yes">HEPACAM</italic> pathogenic variants does not exclude the diagnosis of MLC because (1) the <italic toggle="yes">MLC1</italic> or <italic toggle="yes">HEPACAM</italic> pathogenic variants may not be identifiable with testing methods used or (2) the MLC phenotype may be the result of pathogenic variant(s) in another gene as-yet unidentified gene.</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="mlc.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>When diagnostic criteria including brain MRI findings are met, the diagnosis of MLC is established.</p>
              <p>Note: If the proband fulfills the clinical and MRI criteria, molecular genetic testing is mainly performed to identify the family-specific pathogenic variants for genetic counseling purposes. If no pathogenic variants are found in <italic toggle="yes">MLC1</italic> or <italic toggle="yes">HEPACAM</italic>, the diagnosis of MLC is unchanged.</p>
            </list-item>
            <list-item>
              <p>If the proband does not fulfill diagnostic criteria and, for example, lacks the typical macrocephaly or has equivocal MRI findings, the definitive diagnosis of MLC depends on the results of molecular genetic testing.</p>
              <list list-type="bullet">
                <list-item>
                  <p>For probands with findings consistent with the classic phenotype, molecular genetic testing of <italic toggle="yes">MLC1</italic> is recommended first, followed by molecular genetic testing of <italic toggle="yes">HEPACAM</italic> if no <italic toggle="yes">MLC1</italic> pathogenic variants are identified.</p>
                </list-item>
                <list-item>
                  <p>For probands with findings consistent with the improving phenotype, molecular genetic testing of <italic toggle="yes">HEPACAM</italic> is recommended first.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Carrier testing for relatives</bold> at risk for the autosomal recessive disorders MLC1 and MLC2A requires prior identification of the pathogenic variants in the family.</p>
          <p>Heterozygotes (carriers) of an <italic toggle="yes">MLC1</italic> or <italic toggle="yes">HEPACAM</italic> pathogenic variant associated with the phenotypes MLC1 and MLC2A, respectively, are not at risk of developing MLC.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant(s) in the family.</p>
        </sec>
      </sec>
      <sec id="mlc.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mlc.Clinical_Description">
          <title>Clinical Description</title>
          <p>The two phenotypes observed in megalencephalic leukoencephalopathy with subcortical cysts (MLC) are the classic phenotype and the atypical improving phenotype. When associated with biallelic mutation of <italic toggle="yes">MLC1</italic>, the classic phenotype is known as MLC1; when caused by biallelic mutation of <italic toggle="yes">HEPACAM</italic> it is known as MLC2A. The improving phenotype associated with heterozygous mutation of <italic toggle="yes">HEPACAM</italic> is known as MLC2B.</p>
          <p>To date, macrocephaly has been observed in all individuals with MLC [<xref ref-type="bibr" rid="mlc.REF.van_der_knaap.1995.324">van der Knaap et al 1995</xref>, <xref ref-type="bibr" rid="mlc.REF.gouti_res.1996.439">Gouti&#x000e8;res et al 1996</xref>, <xref ref-type="bibr" rid="mlc.REF.singhal.1996.291">Singhal et al 1996</xref>, <xref ref-type="bibr" rid="mlc.REF.top_u.1998.142">Top&#x000e7;u et al 1998</xref>, <xref ref-type="bibr" rid="mlc.REF.benzeev.2001.93">Ben-Zeev et al 2001</xref>]. It can present at birth but more frequently develops during the first year of life. The degree of macrocephaly is variable; it may be as great as 4 to 6 SD above the mean in some affected individuals. After the first year of life, head growth rate normalizes and growth follows a line parallel to the 98th percentile. In individuals with the atypical improving phenotype, head circumference is initially equally large, but may normalize.</p>
          <p><bold>Classic megalencephalic leukoencephalopathy with subcortical cysts phenotype (MLC1 and MLC2A).</bold> Initial mental and motor development is normal in most children and mildly delayed in some. Apart from progressive macrocephaly, the first clinical sign is usually delay in walking. Walking is often unstable, and the child falls frequently. Subsequently, slow deterioration of motor function is noted over the years with development of ataxia of the trunk and extremities. Signs of pyramidal dysfunction are late and minor and are dominated by the signs of cerebellar ataxia. Muscle tone tends to be low, apart from some ankle hypertonia. Deep-tendon stretch reflexes become brisk, and Babinski signs become apparent. Gradually, the ability to walk independently is lost; and many children become completely wheelchair dependent at the end of the first decade or in the second decade of life.</p>
          <p>Almost all children have epilepsy from early on [<xref ref-type="bibr" rid="mlc.REF.yalcinkaya.2003.388">Yalcinkaya et al 2003</xref>], usually easily controlled with medication.</p>
          <p>Intellectual deterioration is late and mild. Decreasing school performance becomes evident during the later years of primary school. In a minority of children, intellectual capacities are mildly decreased in the early years. Some children develop behavior problems [<xref ref-type="bibr" rid="mlc.REF.sugiura.2006.286">Sugiura et al 2006</xref>]. Speech becomes increasingly dysarthric, and dysphagia may develop. Some individuals display extrapyramidal movement abnormalities with dystonia and athetosis. Some develop tics [<xref ref-type="bibr" rid="mlc.REF.sugiura.2006.286">Sugiura et al 2006</xref>].</p>
          <p>Minor head trauma may induce temporary deterioration in some individuals, most often observed as seizures or status epilepticus, prolonged unconsciousness, or acute motor deterioration with gradual improvement [<xref ref-type="bibr" rid="mlc.REF.bugiani.2003.211">Bugiani et al 2003</xref>].</p>
          <p>Some children have a more severe clinical course and maintain their ability to walk independently only for a few years, or never achieve independent walking.</p>
          <p>Some children have a more benign clinical course and, even as teenagers, only have macrocephaly. Some individuals maintain the ability to walk independently into their forties.</p>
          <p>Because the disease has been known for a relatively short time, little information is available about average life span. Some individuals have died in their teens or twenties; others are alive in their fifties.</p>
          <p><bold>Improving megalencephalic leukoencephalopathy with subcortical cysts phenotype (MLC2B).</bold> In children diagnosed with MLC2B the initial disease course is the same as that in children with the classic phenotype: mental and motor development is normal in most and mildly delayed in some. Apart from progressive macrocephaly, the first clinical sign is usually delay in walking. Walking is often unstable, and the child falls frequently.</p>
          <p>After the second or third year of life, motor function improves or normalizes in most. Neurologic examination may become normal, but some children have persistent hypotonia and clumsiness. Regression does not occur.</p>
          <p>Cognitive function can be normal, but some children have intellectual disability with or without autism. Regression has not been observed.</p>
          <p>Epilepsy and status epilepticus may occur.</p>
          <p>Most children remain macrocephalic; however, some become normocephalic.</p>
          <p>Because the disease has been known for a relatively short time, little information is available about average life span. One child died in status epilepticus at age four years [Authors, unpublished data].</p>
          <p>In families with affected individuals from more than one generation, the proband is usually a child and the affected parent is subsequently diagnosed. Parents with the pathogenic variant often have macrocephaly but normal function. Some have cognitive or behavioral problems or motor clumsiness. Considering the normal health of parents heterozygous for a <italic toggle="yes">HEPACAM</italic> pathogenic variant, it does not appear that a heterozygous <italic toggle="yes">HEPACAM</italic> pathogenic variant shortens life span; however, no formal study has addressed this issue.</p>
        </sec>
        <sec id="mlc.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold>Classic MLC.</bold> No phenotypic difference is evident between individuals with MLC who have identifiable pathogenic variants in <italic toggle="yes">MLC1</italic> (MLC1) and those who have MLC associated with identifiable pathogenic variants in <italic toggle="yes">HEPACAM</italic> (MLC2A).</p>
          <list list-type="bullet">
            <list-item>
              <p>Severity of the phenotype in individuals with MLC1 and MLC2A does not correlate with the specific pathogenic variants found.</p>
            </list-item>
            <list-item>
              <p>In individuals from the same family disease severity and clinical course can vary significantly.</p>
            </list-item>
          </list>
          <p><bold>Improving MLC</bold>. In individuals from the same family disease severity and clinical course can vary significantly. Parents and sibs who have the same variant as the proband can be normal with or without macrocephaly.</p>
        </sec>
        <sec id="mlc.Nomenclature">
          <title>Nomenclature</title>
          <p>Names previously used for MLC:</p>
          <list list-type="bullet">
            <list-item>
              <p>Leukoencephalopathy with swelling and a discrepantly mild course</p>
            </list-item>
            <list-item>
              <p>Leukoencephalopathy with swelling and cysts</p>
            </list-item>
            <list-item>
              <p>Infantile leukoencephalopathy and megalencephaly</p>
            </list-item>
            <list-item>
              <p>Vacuolating leukoencephalopathy</p>
            </list-item>
          </list>
        </sec>
        <sec id="mlc.Prevalence">
          <title>Prevalence</title>
          <p>Megalencephalic leukoencephalopathy with subcortical cysts is a rare disorder with a low carrier rate in the general population. Consequently, the disease is rarer in communities with a low rate of consanguinity and higher in communities with a high rate of consanguinity. The parents of many individuals with classic megalencephalic leukoencephalopathy with subcortical cysts are consanguineous.</p>
          <p>
            <bold>Classic MLC caused by pathogenic variants in <italic toggle="yes">MLC1</italic> (MLC1)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>MLC1 has a higher than expected incidence in populations in which consanguinity is common, such as in Turkey [<xref ref-type="bibr" rid="mlc.REF.top_u.1998.142">Top&#x000e7;u et al 1998</xref>].</p>
            </list-item>
            <list-item>
              <p>Almost all East Indian individuals with MLC1 belong to the Agrawal community; and all individuals within this community have the same pathogenic variant (<xref ref-type="table" rid="mlc.T.selected_mlc1_allelic_variants">c.135insC, p.Cys46LeufsTer34</xref>), providing evidence for a founder effect [<xref ref-type="bibr" rid="mlc.REF.leegwater.2002.279">Leegwater et al 2002</xref>, <xref ref-type="bibr" rid="mlc.REF.singhal.2003.646">Singhal et al 2003</xref>, <xref ref-type="bibr" rid="mlc.REF.gorospe.2004.878">Gorospe et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>MLC1 is also relatively common among Libyan Jews [<xref ref-type="bibr" rid="mlc.REF.benzeev.2001.93">Ben-Zeev et al 2001</xref>]. One common pathogenic variant (<xref ref-type="table" rid="mlc.T.selected_mlc1_allelic_variants">c.176G&#x0003e;A, p.Gly59Glu</xref>) was found in five unrelated Libyan Jewish families [<xref ref-type="bibr" rid="mlc.REF.benzeev.2002.214">Ben-Zeev et al 2002</xref>]. The same variant was identified in several affected individuals from a single Jewish Turkish family descended from the same ancestors. Screening of 200 normal Libyan Jewish individuals for this particular pathogenic variant revealed a carrier rate of one in 40, as compared with an expected carrier rate of one in 81. Non-Jewish Turkish individuals do not share a common pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The <italic toggle="yes">MLC1</italic> pathogenic variant <xref ref-type="table" rid="mlc.T.selected_mlc1_allelic_variants">c.278C&#x0003e;T, p.Ser93Leu</xref> appears to be fairly common in Japanese individuals [<xref ref-type="bibr" rid="mlc.REF.saijo.2003.362">Saijo et al 2003</xref>, <xref ref-type="bibr" rid="mlc.REF.tsujino.2003.605">Tsujino et al 2003</xref>] but has also been observed in Finland, Turkey [<xref ref-type="bibr" rid="mlc.REF.leegwater.2001.831">Leegwater et al 2001</xref>], and Italy [<xref ref-type="bibr" rid="mlc.REF.montagna.2006.292">Montagna et al 2006</xref>].</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="mlc.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>In addition to the phenotypes discussed in this <italic toggle="yes">GeneReview</italic>, pathogenic variants in <italic toggle="yes">MLC1</italic> could be involved in catatonic schizophrenia.</p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="bibr" rid="mlc.REF.meyer.2001.302">Meyer et al [2001]</xref> suggested that a putative dominantly acting missense variant, <xref ref-type="table" rid="mlc.T.selected_mlc1_allelic_variants">p.Leu309Met</xref> was cosegregating in a large pedigree with periodic catatonia.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="mlc.REF.rubie.2003.45">Rubie et al [2003]</xref> screened <italic toggle="yes">MLC1</italic> in 140 index cases with periodic catatonia and five individuals with MLC; their findings and those of <xref ref-type="bibr" rid="mlc.REF.devaney.2002.419">Devaney et al [2002]</xref> and <xref ref-type="bibr" rid="mlc.REF.kaganovich.2004.31">Kaganovich et al [2004]</xref> seemed to exclude <italic toggle="yes">MLC1</italic> as a susceptibility locus for schizophrenia.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="mlc.REF.verma.2005.16">Verma et al [2005]</xref> concluded that rare and common variants in <italic toggle="yes">MLC1</italic> could contribute to schizophrenia and bipolar disorder.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="mlc.REF.selch.2007.1211">Selch et al [2007]</xref> replicated the data from <xref ref-type="bibr" rid="mlc.REF.verma.2005.16">Verma et al [2005]</xref> and narrowed the association of <italic toggle="yes">MLC1</italic> genetic variation to periodic catatonia. Selch et al also stated that &#x0201c;a further possible alternative explanation might be that associated SNPs in <italic toggle="yes">MLC1</italic> are in linkage disequilibrium with a potential &#x02018;true&#x02019; disease-causing variant in a gene nearby&#x0201d; [<xref ref-type="bibr" rid="mlc.REF.selch.2007.1211">Selch et al 2007</xref>].</p>
          </list-item>
        </list>
        <p>Elucidation of the function of <italic toggle="yes">MLC1</italic> and determination of the effects of variants that appear to be associated with a subgroup of schizophrenia are needed to resolve this ongoing debate.</p>
      </sec>
      <sec id="mlc.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of macrocephaly and a diffuse leukoencephalopathy is limited; it includes Canavan disease, Alexander disease, infantile-onset GM2 gangliosidosis, and, on occasion, infantile-onset GM1 gangliosidosis and L-2-hydroxyglutaric aciduria. Some children with congenital muscular dystrophy caused by laminin alpha-2 (merosin) deficiency (also known as MDC1A) have macrocephaly. The clinical features and course of these disorders are usually different from those of MLC. If the head circumference is well within the normal limits at age one year, it is highly unlikely that the infant has MLC. None of these disorders shares all the MRI characteristics of megalencephalic leukoencephalopathy with subcortical cysts (MLC).</p>
        <p><bold>Laminin alpha 2 deficiency.</bold> The white matter disease in laminin alpha-2 deficiency most closely resembles that observed in MLC; however, the typical subcortical cysts are generally lacking [<xref ref-type="bibr" rid="mlc.REF.van_der_knaap.1997.50">van der Knaap et al 1997</xref>]. In addition, individuals with laminin alpha-2 deficiency have prominent weakness and hypotonia, not shared by individuals with MLC. The diagnosis can be confirmed with molecular genetic testing. (See <related-object link-type="booklink" source-id="gene" document-id="cmd-overview" document-type="chapter">Congenital Muscular Dystrophy</related-object>).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="canavan" document-type="chapter"><bold>Canavan disease</bold></related-object><bold>.</bold> The MRI typically shows involvement of the thalamus and globus pallidus with relative sparing of a bilateral crescent formed by the putamen and caudate nucleus. The globus pallidus and thalamus are not involved in MLC. The white matter may be cystic in Canavan disease, but the typical subcortical cysts seen in MLC are lacking. The diagnosis of neonatal/infantile Canavan disease relies on demonstration of very high concentration of N-acetylaspartic acid (NAA) in the urine and/or molecular genetic testing of <italic toggle="yes">ASPA</italic>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="alexander" document-type="chapter"><bold>Alexander disease</bold></related-object><bold>.</bold> Megalencephaly and leukoencephalopathy with frontal predominance of MRI abnormalities are observed [<xref ref-type="bibr" rid="mlc.REF.van_der_knaap.2001.541">van der Knaap et al 2001</xref>]. This predilection for the anterior parts of the brain is not shared by MLC. In Alexander disease, contrast enhancement of particular brain structures is almost invariably observed [<xref ref-type="bibr" rid="mlc.REF.van_der_knaap.2001.541">van der Knaap et al 2001</xref>], whereas contrast enhancement is not a feature of MLC. Cystic degeneration may occur in Alexander disease, but the location of the cysts is different: the deep frontal white matter is mainly affected. The diagnosis of Alexander disease can be confirmed by molecular genetic testing of <italic toggle="yes">GFAP</italic>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="tay-sachs" document-type="chapter"><bold>Infantile GM2 gangliosidosis</bold></related-object><bold>.</bold> The MRI is characterized by prominent involvement of the basal ganglia and thalami in addition to the white matter abnormalities. A definitive diagnosis is established by assaying hexosaminidase A and B in serum, leukocytes, or cultured skin fibroblasts.</p>
        <p><bold>Infantile</bold>
<related-object link-type="booklink" source-id="gene" document-id="gm1-ganglio" document-type="chapter"><bold>GM1 gangliosidosis</bold></related-object><bold>.</bold> MRI findings are very similar to those of GM2 gangliosidosis [<xref ref-type="bibr" rid="mlc.REF.chen.1998.1628">Chen et al 1998</xref>]. Demonstration of deficiency of beta-galactosidase activity in leukocytes or cultured fibroblasts confirms the diagnosis.</p>
      </sec>
      <sec id="mlc.Management">
        <title>Management</title>
        <sec id="mlc.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with megalencephalic leukoencephalopathy with subcortical cysts (MLC) the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination</p>
            </list-item>
            <list-item>
              <p>Brain MRI</p>
            </list-item>
            <list-item>
              <p>Physical therapy/occupational therapy assessment</p>
            </list-item>
            <list-item>
              <p>Assessment of cognitive dysfunction (neuropsychological testing)</p>
            </list-item>
          </list>
        </sec>
        <sec id="mlc.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Supportive therapy includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Antiepileptic drugs (AED) if epileptic seizures are present</p>
            </list-item>
            <list-item>
              <p>Physical therapy to improve motor function</p>
            </list-item>
            <list-item>
              <p>Special education</p>
            </list-item>
            <list-item>
              <p>Speech therapy as needed</p>
            </list-item>
          </list>
        </sec>
        <sec id="mlc.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Minor head trauma may lead to temporary motor deterioration or (rarely) to coma. Wearing a helmet should be considered for situations involving increased risk of head trauma.</p>
        </sec>
        <sec id="mlc.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Minor head trauma may lead to temporary motor deterioration or (rarely) to coma. For this reason contact sports and other activities with a high risk of head trauma should be avoided.</p>
        </sec>
        <sec id="mlc.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="mlc.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mlc.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="mlc.Other">
          <title>Other</title>
          <p>Unsuccessful therapies have included diuretics, acetazolamide, and creatine monohydrate.</p>
        </sec>
      </sec>
      <sec id="mlc.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mlc.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>The classic phenotype of megalencephalic leukoencephalopathy with subcortical cysts (MLC) caused by biallelic mutation of <italic toggle="yes">MLC1</italic> (known as MLC1) or biallelic mutation of <italic toggle="yes">HEPACAM</italic> (known as MLC2A) is inherited in an autosomal recessive manner.</p>
          <p>The improving phenotype of MLC caused by heterozygous mutation of <italic toggle="yes">HEPACAM</italic> (known as MLC2B) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="mlc.Risk_to_Family_Members__Autosomal_Re">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance (MLC1 and MLC2A)</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of a child are obligate heterozygotes and therefore carry one mutant allele.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic. No clinical or MRI abnormalities have been found in heterozygotes (carriers).</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the chance of his/her being a carrier is 2/3.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic. No clinical or MRI abnormalities have been found in heterozygotes (carriers).</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an affected individual are obligate heterozygotes (carriers) for a pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="mlc.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for relatives of the proband is possible once the pathogenic variant(s) have been identified in the family.</p>
        </sec>
        <sec id="mlc.Risk_to_Family_Members__Autosomal_Do">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance (MLC2B)</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals with MLC2B have a parent with macrocephaly. Given the neurologic improvement that is observed in this phenotype, the parent is not at risk of neurologic regression. Whether having a heterozygous <italic toggle="yes">HEPACAM</italic> pathogenic variant leads to other symptoms late in life has not been investigated; however, to date no evidence suggests disease progression later in life.</p>
            </list-item>
            <list-item>
              <p>A proband with MLC2B may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown; they are thought to be rather frequent [<xref ref-type="bibr" rid="mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure to recognize the syndrome and/or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected and/or has a heterozygous <italic toggle="yes">HEPACAM</italic> pathogenic variant, the risk to the sibs of inheriting the variant is 50%.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for MLC2B because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with MLC2B has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="mlc.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mlc.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the pathogenic variant(s) have been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for MLC are possible.</p>
        </sec>
      </sec>
      <sec id="mlc.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mlc.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">MLC1</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">MLC1</italic> comprises 26,214 bases and 13 exons; the cDNA has 3435 base pairs. <italic toggle="yes">MLC1</italic> is mainly expressed in the brain but also in all types of leukocytes. The highest levels have been found within the brain in the caudate nucleus, thalamus, and hippocampus. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mlc" object-id="mlc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> According to the most recent <italic toggle="yes">MLC1</italic> variant update [<xref ref-type="bibr" rid="mlc.REF.ilja_boor.2006.505">Ilja Boor et al 2006</xref>], approximately 50% of pathogenic variants are missense, 28% are frameshifts caused by deletion or insertion, 22% are pathogenic variants in a splice junction, and one (out of 50) is a nonsense variant. (For more information, see <related-object source-id="gene" document-id="mlc" object-id="mlc.molgen.TA">Table A</related-object>.)</p>
        <p><xref ref-type="bibr" rid="mlc.REF.montagna.2006.292">Montagna et al [2006]</xref> reported nine additional novel variants.</p>
        <p>Mutated nucleotides deep within the intron are often best detected by analysis of cDNA, if available, which will reveal the alternative transcripts resulting from aberrant splicing. Examples include c.298_423del126+108del, a deletion of exons 4 and 5 and intronic regions [<xref ref-type="bibr" rid="mlc.REF.ilja_boor.2006.505">Ilja Boor et al 2006</xref>] and <xref ref-type="table" rid="mlc.T.selected_mlc1_allelic_variants">c.178-10T&#x0003e;A</xref> in intron 1. Theoretically, this change would not be predicted to affect splicing; however, cDNA analysis revealed skipping of exon 2, which encodes amino acids 60 through 89 [MS van der Knaap &#x00026; GC Scheper, unpublished data].</p>
        <table-wrap id="mlc.T.selected_mlc1_allelic_variants" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">MLC1</italic> Allelic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                <th id="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_1" rowspan="4" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Benign</bold>
                </td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.512G&#x0003e;T&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys171Phe</td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_4" rowspan="9" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=93141206">NM_015166.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=14589896">NP_055981.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.654C&#x0003e;A&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn218Lys</td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.925C&#x0003e;A&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu309Met</td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1031A&#x0003e;G&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn344Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_1" rowspan="5" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Pathogenic</bold>
                </td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.135insC</td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys46LeufsTer34</td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.176G&#x0003e;A</td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly59Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.178-10T&#x0003e;A</td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.298_423del126+108del&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Thr99fsTer</td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.278C&#x0003e;T</td>
                <td headers="hd_h_mlc.T.selected_mlc1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ser93Leu</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="mlc.TF.2.1">
              <label>1. </label>
              <p>Frequency of normal variants: c.512G&#x0003e;T (9%); c.654C&#x0003e;A (1.5%); c.925C&#x0003e;A (0.7%); c.1031A&#x0003e;G (11%)</p>
            </fn>
            <fn id="mlc.TF.2.2">
              <label>2. </label>
              <p>Describes the deletion of 126 nucleotides in an exon and deletion of 108 additional nucleotides after base 423, which is at a splice donor site. The total deletion of exon and intron sequences is 234 nucleotides.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The MLC1 protein size is 377 amino acids; its predicted molecular weight is 41 kd. MLC1 is an integral membrane protein [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.kazusa.or.jp/huge/gfpage/KIAA0027/">HUGE Protein Database</ext-link>] of unknown function. The protein is localized mainly in the endfeet of astrocytes in the perivascular, subependymal, and subpial regions. The localization suggests a role for <italic toggle="yes">MLC1</italic> in the transport process across the blood-brain barrier and brain-cerebrospinal fluid barrier [<xref ref-type="bibr" rid="mlc.REF.boor.2005.412">Boor et al 2005</xref>, <xref ref-type="bibr" rid="mlc.REF.teijido.2007.532">Teijido et al 2007</xref>]. <xref ref-type="bibr" rid="mlc.REF.teijido.2004.2581">Teijido et al [2004]</xref> reported that in the adult mouse brain <italic toggle="yes">MLC1</italic> is expressed in subsets of neurons, where it localizes primarily in fibers and axonal tracts. In human tissue, the MLC1 protein colocalizes with members of the dystrophin glycoprotein-associated complex [<xref ref-type="bibr" rid="mlc.REF.boor.2007.403">Boor et al 2007</xref>].</p>
        <p><bold>Abnormal gene product.</bold>
<xref ref-type="bibr" rid="mlc.REF.teijido.2004.2581">Teijido et al [2004]</xref> and <xref ref-type="bibr" rid="mlc.REF.montagna.2006.292">Montagna et al [2006]</xref> examined <italic toggle="yes">MLC1</italic> pathogenic variants by measuring the protein expression and the amount of protein at the plasma membrane. All tested <italic toggle="yes">MLC1</italic> pathogenic variants showed a low steady-state expression of MLC1 with a consequent reduction in surface expression.</p>
        <p>In rat primary astrocytes, reduction of MLC1 expression resulted in the appearance of intracellular vacuoles [<xref ref-type="bibr" rid="mlc.REF.duarri.2011.228">Duarri et al 2011</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">HEPACAM</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">HEPACAM</italic> comprises 17,076 bases and seven exons. The cDNA has 3563 base pairs. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mlc" object-id="mlc.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold>
<italic toggle="yes">HEPACAM</italic> pathogenic variants leading to the classic phenotype (MLC2A) are mostly missense; however, nonsense and frame-shift variants have also been observed. In the case of the improving phenotype (MLC2B), only missense variants in <italic toggle="yes">HEPACAM</italic> have been reported [<xref ref-type="bibr" rid="mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</xref>].</p>
        <table-wrap id="mlc.T.selected_hepacam_allelic_variants" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">HEPACAM</italic> Allelic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                <th id="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Pathogenic (MLC2A)</bold>
                </td>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">c.275G&#x0003e;A&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">p.Arg92Gln</td>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_4" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_152722.4">NM_152722.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_689935.2">NP_689935.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Pathogenic (MLC2B)</bold>
                </td>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.265G&#x0003e;A&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly89Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.274C&#x0003e;T</td>
                <td headers="hd_h_mlc.T.selected_hepacam_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg92Trp</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="mlc.TF.3.1">
              <label>1. </label>
              <p>The pathogenic missense variant c.274C&#x0003e;T, p.Arg92Trp, which involves this same amino acid, is among the most common pathogenic variants in MLC2B.</p>
            </fn>
            <fn id="mlc.TF.3.2">
              <label>2. </label>
              <p>Most common pathogenic variant in MLC2B (6 of 16 cases in <xref ref-type="bibr" rid="mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al [2011]</xref>)</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The size of the protein encoded by <italic toggle="yes">HEPACAM</italic>, the hepatic and glial cell adhesion molecule (called either HepaCAM or GlialCAM) [<xref ref-type="bibr" rid="mlc.REF.chung_moh.2005.833">Chung Moh et al 2005</xref>, <xref ref-type="bibr" rid="mlc.REF.favrekontula.2008.633">Favre-Kontula et al 2008</xref>] is 417 amino acids; its predicted molecular weight is 46 kd.</p>
        <p><italic toggle="yes">HEPACAM</italic> is mainly expressed in the brain, with the highest expression in white matter tracts of the central nervous system, in ependymal cells of the brain ventricular zones, and in the central canal of the spinal cord [<xref ref-type="bibr" rid="mlc.REF.favrekontula.2008.633">Favre-Kontula et al 2008</xref>]. GlialCAM is a single transmembrane protein with two extracellular immunoglobulin domains. Although originally identified in hepatocellular carcinoma cell lines (hence its name HepaCAM), it is predominantly expressed in the brain, where it is present in astrocytes, oligodendrocytes, and neurons.</p>
        <p>A role for GlialCAM in myelination is supported by its upregulation during postnatal mouse brain development, where it is concomitantly expressed with myelin basic protein (MBP). In addition, in vitro, GlialCAM is observed in various developmental stages of oligodendrocytes and in astrocytic processes and at cell contact sites [<xref ref-type="bibr" rid="mlc.REF.favrekontula.2008.633">Favre-Kontula et al 2008</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Mutated GlialCAM is not properly localized at the cell membrane in cell-cell contacts.</p>
        <p>In cultured rat primary astrocytes, mutated GlialCAM with either a dominant or a recessive pathogenic variant causes mislocalization of MLC1. Coexpression of wild type GlialCAM rescues the detrimental effect of GlialCAM with a recessive variant on MLC1 localization, but it does not rescue the effect of the dominant variant of GlialCAM [<xref ref-type="bibr" rid="mlc.REF.l_pezhern_ndez.2011.422">L&#x000f3;pez-Hern&#x000e1;ndez et al 2011</xref>].</p>
      </sec>
      <sec id="mlc.References">
        <title>References</title>
        <sec id="mlc.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mlc.Literature_Cited.reflist0">
            <ref id="mlc.REF.benzeev.2001.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ben-Zeev</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kushnir</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shalev</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinar</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pras</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brand</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients.</article-title>
                <source>J Child Neurol</source>
                <volume>16</volume>
                <fpage>93</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11292232</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.benzeev.2002.214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ben-Zeev</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy-Nissenbaum</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lahat</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anikster</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinar</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross-Tzur</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacGregor</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frydman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pras</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Megalencephalic leukoencephalopathy with subcortical cysts; a founder effect in Israeli patients and a higher than expected carrier rate among Libyan Jews.</article-title>
                <source>Hum Genet</source>
                <volume>111</volume>
                <fpage>214</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12189496</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.boor.2007.403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagtegaal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamphorst</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Valk</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Horssen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinopoulos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bove</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual-Castroviejo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Est&#x000e9;vez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>MLC1 is associated with the dystrophin-glycoprotein complex at astrocytic endfeet.</article-title>
                <source>Acta Neuropathol</source>
                <volume>114</volume>
                <fpage>403</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">17628813</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.boor.2005.412">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Groot</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waisfisz</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamphorst</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudejans</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>MLC1: a novel protein in distal astroglial processes.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>64</volume>
                <fpage>412</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15892299</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.bugiani.2003.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bugiani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bizzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardocci</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bettecken</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e4;rtner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Consciousness disturbances in megalencephalic leukoencephalopathy with subcortical cysts.</article-title>
                <source>Neuropediatrics</source>
                <volume>34</volume>
                <fpage>211</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">12973663</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.chen.1998.1628">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuh</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsiao</surname>
                    <given-names>HS</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Neuroimaging findings in late infantile GM1 gangliosidosis.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>19</volume>
                <fpage>1628</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">9802482</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.chung_moh.2005.833">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chung Moh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoon Lee</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma.</article-title>
                <source>J Hepatol.</source>
                <volume>42</volume>
                <fpage>833</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">15885354</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.devaney.2002.419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Devaney</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donarum</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;ber</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesch</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nestadt</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephan</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pulver</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>No missense mutation of WKL1 in a subgroup of probands with schizophrenia.</article-title>
                <source>Mol Psychiatry</source>
                <volume>7</volume>
                <fpage>419</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">11986987</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.duarri.2011.228">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Duarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Heredia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capdevila-Nortes</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ridder</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montolio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez-Hern&#x000e1;ndez</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lien</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagemann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messing</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorecki</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunes</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Est&#x000e9;vez</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Knockdown of MLC1 in primary astrocytes causes cell vacuolation: A MLC disease cell model.</article-title>
                <source>Neurobiol Dis</source>
                <volume>43</volume>
                <fpage>228</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">21440627</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.favrekontula.2008.633">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Favre-Kontula</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rolland</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernasconi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karmirantzou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Power</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonsson</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boschert</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>GlialCAM, an immunoglobulin-like cell adhesion molecule is expressed in glial cells of the central nervous system.</article-title>
                <source>Glia</source>
                <volume>56</volume>
                <fpage>633</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">18293412</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.gorospe.2004.878">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gorospe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singhal</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kainu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trent</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffman</surname>
                    <given-names>EP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>878</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">15037685</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.gouti_res.1996.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gouti&#x000e8;res</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulloche</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourgeois</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aicardi</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Leukoencephalopathy, megalencephaly, and mild clinical course. A recently individualized familial leukodystrophy. Report on five new cases.</article-title>
                <source>J Child Neurol</source>
                <volume>11</volume>
                <fpage>439</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">9120220</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.ilja_boor.2006.505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ilja Boor</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Groot</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mejaski-Bosnjak</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Megalencephalic leukoencephalopathy with subcortical cysts: an update and extended mutation analysis of MLC1.</article-title>
                <source>Hum Mutat</source>
                <volume>27</volume>
                <fpage>505</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">16652334</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.itoh.2006.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maeda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzuhara</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>An adult case of megalencephalic leukoencephalopathy with subcortical cysts with S93L mutation in MLC1 gene: a case report and diffusion MRI.</article-title>
                <source>Eur Neurol</source>
                <volume>56</volume>
                <fpage>243</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17077634</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.kaganovich.2004.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaganovich</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peretz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritsner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bening Abu-Shach</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attali</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navon</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Is the WKL1 gene associated with schizophrenia?</article-title>
                <source>Am J Med Genet B Neuropsychiatr Genet.</source>
                <volume>125B</volume>
                <fpage>31</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14755440</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.leegwater.2002.279">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leegwater</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>BQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Steen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Visser</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konst</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudejans</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schutgens</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts.</article-title>
                <source>Hum Genet</source>
                <volume>110</volume>
                <fpage>279</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">11935341</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.leegwater.2001.831">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leegwater</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>BQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Steen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulders</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konst</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boor</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mejaski-Bosnjak</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Maarel</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oudejans</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schutgens</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pronk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>831</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11254442</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.l_pezhern_ndez.2011.422">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000f3;pez-Hern&#x000e1;ndez</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ridder</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montolio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capdevila-Nortes</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polder</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sirisi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duarri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulte</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fakler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunes</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Est&#x000e9;vez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism.</article-title>
                <source>Am J Hum Genet</source>
                <volume>88</volume>
                <fpage>422</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">21419380</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.meyer.2001.302">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huberth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ortega</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syagailo</surname>
                    <given-names>YV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jatzke</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mossner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ulzheimer-Teuber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stober</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesch</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree.</article-title>
                <source>Mol Psychiatry</source>
                <volume>6</volume>
                <fpage>302</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11326298</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.montagna.2006.292">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teijido</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard-Pierre</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muraki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loizzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grosso</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tedeschi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palac&#x000ed;n</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Est&#x000e9;vez</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Vacuolating megalencephalic leukoencephalopathy with subcortical cysts: functional studies of novel variants in MLC1.</article-title>
                <source>Hum Mutat</source>
                <volume>27</volume>
                <fpage>292</fpage>
                <pub-id pub-id-type="pmid">16470554</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.rubie.2003.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rubie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gartner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siekiera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohlschutter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stober</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bettecken</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Sequence diversity of KIAA0027/MLC1: are megalencephalic leukoencephalopathy and schizophrenia allelic disorders?</article-title>
                <source>Hum Mutat</source>
                <volume>21</volume>
                <fpage>45</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">12497630</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.saijo.2003.362">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saijo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ezoe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sone</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamaguchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiroma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanazawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirayama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arima</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A case of megalencephalic leukoencephalopathy with subcortical cysts (van der Knaap disease): molecular genetic study.</article-title>
                <source>Brain Dev</source>
                <volume>25</volume>
                <fpage>362</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12850517</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.selch.2007.1211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Selch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strobel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haderlein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacob</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesch</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reif</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>MLC1 polymorphisms are specifically associated with periodic catatonia, a subgroup of chronic schizophrenia.</article-title>
                <source>Biol Psychiatry</source>
                <volume>61</volume>
                <fpage>1211</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17210142</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.singhal.2003.646">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singhal</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorospe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Megalencephalic leukoencephalopathy with subcortical cysts.</article-title>
                <source>J Child Neurol</source>
                <volume>18</volume>
                <fpage>646</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">14572144</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.singhal.1996.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singhal</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gursahani</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udani</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biniwale</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Megalencephalic leukodystrophy in an Asian Indian ethnic group.</article-title>
                <source>Pediatr Neurol</source>
                <volume>14</volume>
                <fpage>291</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8805171</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.sugiura.2006.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sugiura</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiota</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maegaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koeda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitahara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Late-onset neuropsychological symptoms in a Japanese patient with megalencephalic leukoencephalopathy with subcortical cysts.</article-title>
                <source>Neuropediatrics</source>
                <volume>37</volume>
                <fpage>286</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">17236107</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.teijido.2007.532">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teijido</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casaroli-Marano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kharkovets</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguado</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorzano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palac&#x000ed;n</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soriano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Est&#x000e9;vez</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Expression patterns of MLC1 protein in the central and peripheral nervous systems.</article-title>
                <source>Neurobiol Dis</source>
                <volume>26</volume>
                <fpage>532</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">17434314</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.teijido.2004.2581">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teijido</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zorzano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soriano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del R&#x000ed;o</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palac&#x000ed;n</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Est&#x000e9;vez</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Localization and functional analyses of the MLC1 protein involved in megalencephalic leukoencephalopathy with subcortical cysts.</article-title>
                <source>Hum Mol Genet</source>
                <volume>13</volume>
                <fpage>2581</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">15367490</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.top_u.1998.142">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Top&#x000e7;u</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saatci</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topcuoglu</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kose</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunak</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Megalencephaly and leukodystrophy with mild clinical course: a report on 12 new cases.</article-title>
                <source>Brain Dev</source>
                <volume>20</volume>
                <fpage>142</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">9628190</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.tsujino.2003.605">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsujino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanazawa</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoneyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimono</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawakami</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatanaka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oba</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A common mutation and a novel mutation in Japanese patients with van der Knaap disease.</article-title>
                <source>J Hum Genet</source>
                <volume>48</volume>
                <fpage>605</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14615938</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.van_der_knaap.1995.324">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroink</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nieuwenhuizen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arts</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogenraad</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children.</article-title>
                <source>Ann Neurol</source>
                <volume>37</volume>
                <fpage>324</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">7695231</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.van_der_knaap.1996.206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vrensen</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>92</volume>
                <fpage>206</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">8841668</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.van_der_knaap.2001.541">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naidu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breiter</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blaser</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroink</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Springer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Begeer</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Coster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>NH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powers</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Alexander disease: diagnosis with MR imaging.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>22</volume>
                <fpage>541</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">11237983</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.van_der_knaap.1997.50">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smit</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catsman-Berrevoets</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouwer</surname>
                    <given-names>OF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Begeer</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valk</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities.</article-title>
                <source>Ann Neurol</source>
                <volume>42</volume>
                <fpage>50</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9225685</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.van_der_voorn.2006.510">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Voorn</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouwels</surname>
                    <given-names>PJW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrarens</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremer</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkhof</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Childhood white matter disorders: quantitative MR imaging and spectroscopy.</article-title>
                <source>Radiology</source>
                <volume>241</volume>
                <fpage>510</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">17057071</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.verma.2005.16">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verma</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukerji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grover</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>B-Rao C, Das SK, Kubendran S, Jain S, Brahmachari SK. MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India.</article-title>
                <source>Biol Psychiatry.</source>
                <year>2005</year>
                <month>Jul</month>
                <day>1</day>
                <volume>58</volume>
                <issue>1</issue>
                <fpage>16</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15992519</pub-id>
              </element-citation>
            </ref>
            <ref id="mlc.REF.yalcinkaya.2003.388">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yalcinkaya</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuksel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilic</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cokar</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dervent</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Epilepsy in vacuolating megalencephalic leukoencephalopathy with subcortical cysts.</article-title>
                <source>Seizure</source>
                <volume>12</volume>
                <fpage>388</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">12915085</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="mlc.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="mlc.Suggested_Reading.reflist0">
            <ref id="mlc.REF38">
              <mixed-citation publication-type="web">Kazusa Human cDNA Project. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.kazusa.or.jp/huge/gfpage/KIAA0027/">Database</ext-link> of human unidentified gene-encoded (HUGE) large proteins analyzed.</mixed-citation>
            </ref>
            <ref id="mlc.REF.van_der_knaap.2010.834">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000f6;hler</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fonseca</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benke</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayakar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aine</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dom</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000e1;lm&#x000e1;nchey</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietsch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Errami</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheper</surname>
                    <given-names>GC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Megalencephalic leukoencephalopathy with cysts without MLC1 defect.</article-title>
                <source>Ann Neurol</source>
                <volume>67</volume>
                <fpage>834</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20517947</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mlc.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="mlc.Author_History">
          <title>Author History</title>
          <p>JC Pronk, PhD; Vrije Universiteit Medical Center, Amsterdam (2003-2008)Gert C Scheper, PhD (2008-present)Marjo S van der Knaap, MD, PhD (2003-present)</p>
        </sec>
        <sec id="mlc.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>3 November 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 July 2008 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 November 2005 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>11 August 2003 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>12 June 2003 (mvdk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="mlc.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Brain images of an individual with MLC (A, C) and an unaffected individual (B, D)A. Transverse T<sub>2</sub>-weighted image of a child age nine years with MLC, showing diffusely abnormal and mildly swollen white matterB. Transverse T<sub>2</sub>-weighted image of an unaffected childC. Sagittal T<sub>1</sub>-weighted image of the same affected child, showing subcortical cysts in the anterior-temporal and parietal areas (arrows). D. Sagittal T<sub>1</sub>-weighted image of the unaffected child</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mlc-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
